Takara Bio Market Cap

Takara Bio has a market cap or net worth of 101.63 billion as of February 28, 2025. Its market cap has decreased by -32.21% in one year.

Market Cap

101.63B

Enterprise Value

73.23B

Revenue

43.05B

Ranking

n/a

PE Ratio

n/a

Stock Price

867.00

Market Cap Chart

Since December 7, 2004, Takara Bio's market cap has increased from 54.50B to 101.63B, an increase of 86.49%. That is a compound annual growth rate of 3.13%.

Market Cap History

Date	Market Cap	% Change
Feb 28, 2025	101.63B	-19.62%
Dec 30, 2024	126.44B	-16.13%
Dec 29, 2023	150.76B	-27.34%
Dec 30, 2022	207.48B	-34.83%
Dec 30, 2021	318.38B	-4.48%
Dec 30, 2020	333.31B	34.56%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	12.94T
Takeda Pharmaceutical Company	6,787.80B
Daiichi Sankyo Company	6,484.23B
HOYA Corporation	6,210.02B
Otsuka Holdings	3,947.09B
Terumo	3,938.77B
Astellas Pharma	2,675.32B
Olympus	2,343.48B

Market Cap Rankings